News Gilead Sciences, Inc.

Equities

GILD

US3755581036

Market Closed - Nasdaq Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
64.26 ^USD	+0.28%		-2.16%	-20.68%

May. 31	Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival	RE
May. 31	Gilead Sciences Says Phase 3 Study Shows Trodelvy Cut Risk of Death by 16% in Non-Small Cell Lung Cancer Patients	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival	May. 31	RE
Gilead Sciences Says Phase 3 Study Shows Trodelvy Cut Risk of Death by 16% in Non-Small Cell Lung Cancer Patients	May. 31	MT
Disaster averted	May. 31
EVOKE-01 Study Results in Metastatic NSCLC to Be Presented at an Oral Session at ASCO 2024	May. 31	BU
Gilead Sciences, Inc. Announces Detailed Results from the Phase 3 Evoke-01 Study	May. 31	CI
Gilead Sciences Says Phase 3 Trial in Urothelial Cancer Misses Primary Target	May. 30	MT
Gilead's Trodelvy fails to meet main goal in late-stage study	May. 30	RE
Gilead Provides Update on Phase 3 TROPiCS-04 Study	May. 30	BU
Gilead Sciences, Inc. Provides Update on Phase 3 Tropics-04 Study	May. 30	CI
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies against Novel Targets and Target Pairs	May. 29	AQ
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024	May. 22	BU
Gilead Sciences - Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis	May. 20	AQ
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis	May. 18	BU
Transcript : Gilead Sciences, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-15-2024 10:30 AM	May. 15
Transcript : Gilead Sciences, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM	May. 14
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy	May. 14	BU
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	May. 09	BU
Declaration of Voting Results by Gilead Sciences	May. 09	CI
Declaration of Voting Results by Gilead Sciences	May. 09	CI
Declaration of Voting Results by Gilead Sciences	May. 09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Gilead Sciences, Inc.

Equities

GILD

US3755581036

Summary

Filters